These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 9140675

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension.
    Cerasola G, Cottone S, Mangano MT, D'Ignoto G, Pinto A, Carone MB.
    Clin Ther; 1988; 10(6):694-703. PubMed ID: 2975530
    [Abstract] [Full Text] [Related]

  • 3. Persistence of the natriuretic effect of calcium entry blockers.
    Ruilope LM, Miranda B, Oliet A, Alcazar JM, Bigorra J, Rodicio JL.
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S136-9. PubMed ID: 2468857
    [Abstract] [Full Text] [Related]

  • 4. Renal effects of nitrendipine monotherapy in essential hypertension.
    Thananopavarn C, Golub MS, Eggena P, Barrett JD, Sambhi MP.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1032-6. PubMed ID: 6085362
    [Abstract] [Full Text] [Related]

  • 5. Renal effects of nitrendipine.
    Ruilope LM.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S10-3. PubMed ID: 1725795
    [Abstract] [Full Text] [Related]

  • 6. Saluretic and diuretic effects of antihypertensive nitrendipine monotherapy in man.
    Sambhi MP.
    Angiology; 1988 Jan; 39(1 Pt 2):106-12. PubMed ID: 3341609
    [Abstract] [Full Text] [Related]

  • 7. Natriuretic effect of calcium-channel blockers in hypertensives.
    Krishna GG, Riley LJ, Deuter G, Kapoor SC, Narins RG.
    Am J Kidney Dis; 1991 Nov; 18(5):566-72. PubMed ID: 1951336
    [Abstract] [Full Text] [Related]

  • 8. The natriuretic effect of the dihydropyridine calcium antagonist felodipine: a placebo-controlled study involving intravenous angiotensin II in normotensive volunteers.
    Sluiter HE, Wetzels JF, Huysmans FT, Koene RA.
    J Cardiovasc Pharmacol; 1987 Nov; 10 Suppl 10():S154-61. PubMed ID: 2455121
    [Abstract] [Full Text] [Related]

  • 9. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
    Richards AM, Crozier IG, Espiner EA, Ikram H, Yandle TG, Kosoglou T, Rallings M, Frampton C.
    J Cardiovasc Pharmacol; 1992 Nov; 20(5):735-41. PubMed ID: 1280735
    [Abstract] [Full Text] [Related]

  • 10. Nitrendipine and renal tubular function in human volunteers.
    Forsyth DR, Roberts CJ.
    J Clin Pharmacol; 1992 Mar; 32(3):284-9. PubMed ID: 1564134
    [Abstract] [Full Text] [Related]

  • 11. Effect of nitrendipine on renal function and on hormonal parameters after intravascular iopromide.
    Madsen JK, Jensen JW, Sandermann J, Johannesen N, Paaske WP, Egeblad M, Pedersen EB.
    Acta Radiol; 1998 Jul; 39(4):375-80. PubMed ID: 9685822
    [Abstract] [Full Text] [Related]

  • 12. Dose-dependent effects of felodipine on diuresis and natriuresis in healthy subjects.
    Bengtsson-Hasselgren B, Edgar B, Rönn O.
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):134-9. PubMed ID: 2459543
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Dose-response curves of the different effects.
    Rupoli L, Fruscio M, Gradnik R, Chianca R, Leonetti G, Zanchetti A.
    Am J Med; 1989 Apr 17; 86(4A):65-6. PubMed ID: 2523658
    [Abstract] [Full Text] [Related]

  • 14. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA, Marcó E, Gilbert HB, Raffaele P, Brito M, Giménez M, Moledo LI.
    Drugs; 1985 Apr 17; 30 Suppl 1():49-58. PubMed ID: 2994987
    [Abstract] [Full Text] [Related]

  • 15. Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension?
    van Paassen P, de Zeeuw D, Navis G, de Jong PE.
    Hypertension; 1996 Feb 17; 27(2):202-8. PubMed ID: 8567042
    [Abstract] [Full Text] [Related]

  • 16. Enhanced natriuretic response to neutral endopeptidase inhibition in patients with moderate chronic renal failure.
    Lipkin GW, Dawnay AB, Harwood SM, Cattell WR, Raine AE.
    Kidney Int; 1997 Sep 17; 52(3):792-801. PubMed ID: 9291201
    [Abstract] [Full Text] [Related]

  • 17. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
    Vervoort G, Hertenberg F, Wetzels JF, Smits P.
    J Hypertens; 1998 Feb 17; 16(2):245-50. PubMed ID: 9535153
    [Abstract] [Full Text] [Related]

  • 18. [The effects of the acute administration of atrial natriuretic peptide on the mechanisms regulating diuresis and natriuresis in the essential hypertension patient].
    Iannettone CM, Strazzulla G, Fabbri G, Piazza E, Valenza T, De Feo ML, Franchi F.
    Ann Ital Med Int; 1991 Feb 17; 6(3):273-83. PubMed ID: 1837999
    [Abstract] [Full Text] [Related]

  • 19. Effects of rapamycin on renal hemodynamics, water and sodium excretion, and plasma levels of angiotensin II, aldosterone, atrial natriuretic peptide, and vasopressin in pigs.
    Golbaekdal K, Nielsen CB, Djurhuus JC, Pedersen EB.
    Transplantation; 1994 Dec 15; 58(11):1153-7. PubMed ID: 7992354
    [Abstract] [Full Text] [Related]

  • 20. Hemodynamic and renal effects of low-dose brain natriuretic peptide infusion in humans: a randomized, placebo-controlled crossover study.
    van der Zander K, Houben AJ, Hofstra L, Kroon AA, de Leeuw PW.
    Am J Physiol Heart Circ Physiol; 2003 Sep 15; 285(3):H1206-12. PubMed ID: 12738624
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.